English

FRESH TRACKS THERAPEUTICS, INC.

EDGAR

BBI Annual report (10-K) · filed 2024-03-15

131 filing records in this dataset, filed from 1996-08-13 to 2024-03-15. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2023 Q4 · USD

Exact inputs and evidence

Revenue: 8006000 USD Source
Revenue: 8006000 USD Source

Operating cash flow

-1.1 million USD

2023 Q4 · USD

Exact inputs and evidence

Operating Cash Flow: -4300000 USD Source
Operating Cash Flow: -3200000 USD Source

Cash and cash equivalents: 10.9 million USD 2023-12-31 Source
Exact value

10900000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 5.97 million shares 2023-12-31 Source
Exact value

5973306 shares

Reported share-count change

97.86% · 2.95 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

3018940 shares · 2022-12-31· Source
5973306 shares · 2023-12-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

8.01 million USD

2023-01-01 – 2023-12-31

Exact inputs and evidence

Revenue: 9000 USD · 2023-01-01 – 2023-03-31 Source
Revenue: 53000 USD · 2023-04-01 – 2023-06-30 Source
Revenue: 7944000 USD · 2023-07-01 – 2023-09-30 Source
Revenue: 8006000 USD · 2023-01-01 – 2023-12-31 Source
Revenue: 8006000 USD · 2023-01-01 – 2023-09-30 Source

Net income

-5.66 million USD

2023-01-01 – 2023-12-31

Exact inputs and evidence

Net income: -4276000 USD · 2023-01-01 – 2023-03-31 Source
Net income: -2284000 USD · 2023-04-01 – 2023-06-30 Source
Net income: 2104000 USD · 2023-07-01 – 2023-09-30 Source
Net income: -5700000 USD · 2023-01-01 – 2023-12-31 Source
Net income: -4500000 USD · 2023-01-01 – 2023-09-30 Source

Operating cash flow

-4.3 million USD

2023-01-01 – 2023-12-31

Exact inputs and evidence

Operating cash flow: -4500000 USD · 2023-01-01 – 2023-03-31 Source
Operating cash flow: -6300000 USD · 2023-01-01 – 2023-06-30 Source
Operating cash flow: -4500000 USD · 2023-01-01 – 2023-03-31 Source
Operating cash flow: -3200000 USD · 2023-01-01 – 2023-09-30 Source
Operating cash flow: -6300000 USD · 2023-01-01 – 2023-06-30 Source
Operating cash flow: -4300000 USD · 2023-01-01 – 2023-12-31 Source
Operating cash flow: -3200000 USD · 2023-01-01 – 2023-09-30 Source

Capital expenditure

36 thousand USD

2018-01-01 – 2018-12-31

Exact inputs and evidence

Capital expenditure: 0 USD · 2018-01-01 – 2018-03-31 Source
Capital expenditure: 16000 USD · 2018-01-01 – 2018-06-30 Source
Capital expenditure: 0 USD · 2018-01-01 – 2018-03-31 Source
Capital expenditure: 35000 USD · 2018-01-01 – 2018-09-30 Source
Capital expenditure: 16000 USD · 2018-01-01 – 2018-06-30 Source
Capital expenditure: 36000 USD · 2018-01-01 – 2018-12-31 Source
Capital expenditure: 35000 USD · 2018-01-01 – 2018-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2024-03-15.

Financial data available through: 2023-12-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2023-12-31
Operating income: 11 of 11 periods available· newest 2023-12-31
Net income: 11 of 11 periods available· newest 2023-12-31
Operating cash flow: 11 of 11 periods available· newest 2023-12-31
Capital expenditure: 6 of 11 periods available· newest 2018-12-31
Total assets: 11 of 11 periods available· newest 2023-12-31
Total liabilities: 4 of 11 periods available· newest 2021-12-31
Current assets: 11 of 11 periods available· newest 2023-12-31
Current liabilities: 11 of 11 periods available· newest 2023-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2023-12-31
long term debt: No compatible figures in this window
Shares outstanding: 11 of 11 periods available· newest 2023-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+15.3%

Prior period

USD 6.94 million

2022-01-01 – 2022-12-31
Current period

USD 8.01 million

2023-01-01 – 2023-12-31

Exact inputs and evidence

8006000 − 6943000 = 1063000 USD

6943000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
8006000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · FRESH TRACKS THERAPEUTICS, INC. · 2023-12-31 FRESH TRACKS THERAPEUTICS, INC. (edgar:819050) Year-over-year change in Revenue: 1063000 USD Concept: fundies:Revenue Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T23:21:12Z Snapshot: d7dec2b3313a76aff5bd50f95287bb05718949d9458a3dea1eeaf4e9f897a57d Dimensions: Consolidated View: https://fundies.io/companies/edgar/819050?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 8006000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/819050/000162828024011460/frtx-20231231.htm#463691 Filing: 000162828024011460 Input fundies:Revenue: 6943000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/819050/000162828024011460/frtx-20231231.htm#464350 Filing: 000162828024011460
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 15.4 million

Prior period

−USD 21.1 million

2022-01-01 – 2022-12-31
Current period

−USD 5.7 million

2023-01-01 – 2023-12-31

Exact inputs and evidence

-5700000 − -21102000 = 15402000 USD

-21102000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
-5700000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · FRESH TRACKS THERAPEUTICS, INC. · 2023-12-31 FRESH TRACKS THERAPEUTICS, INC. (edgar:819050) Year-over-year change in Net income: 15402000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T23:21:12Z Snapshot: d7dec2b3313a76aff5bd50f95287bb05718949d9458a3dea1eeaf4e9f897a57d Dimensions: Consolidated View: https://fundies.io/companies/edgar/819050?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -5700000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/819050/000162828024011460/frtx-20231231.htm#614789 Filing: 000162828024011460 Input fundies:NetIncome: -21102000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/819050/000162828024011460/frtx-20231231.htm#572835 Filing: 000162828024011460
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 15.04 million

Prior period

−USD 19.34 million

2022-01-01 – 2022-12-31
Current period

−USD 4.3 million

2023-01-01 – 2023-12-31

Exact inputs and evidence

-4300000 − -19335000 = 15035000 USD

-19335000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
-4300000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · FRESH TRACKS THERAPEUTICS, INC. · 2023-12-31 FRESH TRACKS THERAPEUTICS, INC. (edgar:819050) Year-over-year change in Operating cash flow: 15035000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T23:21:12Z Snapshot: d7dec2b3313a76aff5bd50f95287bb05718949d9458a3dea1eeaf4e9f897a57d Dimensions: Consolidated View: https://fundies.io/companies/edgar/819050?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -4300000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/819050/000162828024011460/frtx-20231231.htm#615018 Filing: 000162828024011460 Input fundies:OperatingCashFlow: -19335000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/819050/000162828024011460/frtx-20231231.htm#587942 Filing: 000162828024011460
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2023 2023-01-01 – 2023-12-31

Revenue USD 8.01 million 100% of revenue
Operating costs Derived USD 14.37 million 179% of revenue
Operating income −USD 6.36 million −79% of revenue
Tax, interest and other Derived −USD 660,000 −8.2% of revenue
Net income −USD 5.7 million −71% of revenue

Cash

Operating cash flow −USD 4.3 million −54% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2014 Operating loss: operating costs were 209% of revenue.
2015 Operating loss: operating costs were 145% of revenue.
2016 Operating loss: operating costs were 163% of revenue.
2017 Operating loss: operating costs were 197% of revenue.
2018 Operating loss: operating costs were 178% of revenue.
2019 Operating loss: operating costs were 409% of revenue.
2020 Operating loss: operating costs were 1,251% of revenue.
2021 Operating loss: operating costs were 10,061% of revenue.
2022 Operating loss: operating costs were 410% of revenue.
2023 Operating loss: operating costs were 179% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2014 2014-01-01 – 2014-12-31	15217000	31843000 Derived	-16626000	-134000 Derived	-16492000	-9891000 Derived	Source 2014-01-01 – 2014-12-31: 15217000 USD Inspect Revenue Open source 2014-01-01 – 2014-12-31: -16626000 USD Inspect Operating Income Open source 2014-01-01 – 2014-12-31: -16492000 USD Inspect Net Income Open source 2014-01-01 – 2014-12-31: -9806000 USD Inspect Operating Cash Flow Open source 2014-01-01 – 2014-12-31: 85000 USD Inspect Capital Expenditure Open source
2015 2015-01-01 – 2015-12-31	20950000	30354000 Derived	-9404000	-166000 Derived	-9238000	-7020000 Derived	Source 2015-01-01 – 2015-12-31: 20950000 USD Inspect Revenue Open source 2015-01-01 – 2015-12-31: -9404000 USD Inspect Operating Income Open source 2015-01-01 – 2015-12-31: -9238000 USD Inspect Net Income Open source 2015-01-01 – 2015-12-31: -6948000 USD Inspect Operating Cash Flow Open source 2015-01-01 – 2015-12-31: 72000 USD Inspect Capital Expenditure Open source
2016 2016-01-01 – 2016-12-31	14531000	23708000 Derived	-9177000	-204000 Derived	-8973000	-8643000 Derived	Source 2016-01-01 – 2016-12-31: 14531000 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -9177000 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -8973000 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: -8388000 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 255000 USD Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	13819000	27205000 Derived	-13386000	-426000 Derived	-12960000	-8681000 Derived	Source 2017-01-01 – 2017-12-31: 13819000 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -13386000 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -12960000 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -8601000 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 80000 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	10888000	19339000 Derived	-8451000	785000 Derived	-9236000	3931000 Derived	Source 2018-01-01 – 2018-12-31: 10888000 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -8451000 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -9236000 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: 3967000 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 36000 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	7917000	32385000 Derived	-24468000	-591000 Derived	-23877000	Unavailable	Source 2019-01-01 – 2019-12-31: 7917000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -24468000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -23877000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -35981000 USD Inspect Operating Cash Flow Open source
2020 2020-01-01 – 2020-12-31	1822000	22798000 Derived	-20976000	-63000 Derived	-20913000	Unavailable	Source 2020-01-01 – 2020-12-31: 1822000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -20976000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -20913000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -20034000 USD Inspect Operating Cash Flow Open source
2021 2021-01-01 – 2021-12-31	404000	40648000 Derived	-40244000	-770000 Derived	-39474000	Unavailable	Source 2021-01-01 – 2021-12-31: 404000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -40244000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -39474000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -36148000 USD Inspect Operating Cash Flow Open source
2022 2022-01-01 – 2022-12-31	6943000	28477000 Derived	-21534000	-432000 Derived	-21102000	Unavailable	Source 2022-01-01 – 2022-12-31: 6943000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -21534000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -21102000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -19335000 USD Inspect Operating Cash Flow Open source
2023 2023-01-01 – 2023-12-31	8006000	14366000 Derived	-6360000	-660000 Derived	-5700000	Unavailable	Source 2023-01-01 – 2023-12-31: 8006000 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -6360000 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -5700000 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: -4300000 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 8M 2023

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20142014-12-31	Revenue	15217000	Revenue: 15217000 Open source
20152015-12-31	Revenue	20950000	Revenue: 20950000 Open source
20162016-12-31	Revenue	14531000	Revenue: 14531000 Open source
20172017-12-31	Revenue	13819000	Revenue: 13819000 Open source
20182018-12-31	Revenue	10888000	Revenue: 10888000 Open source
20192019-12-31	Revenue	7917000	Revenue: 7917000 Open source
20202020-12-31	Revenue	1822000	Revenue: 1822000 Open source
20212021-12-31	Revenue	404000	Revenue: 404000 Open source
20222022-12-31	Revenue	6943000	Revenue: 6943000 Open source
20232023-12-31	Revenue	8006000	Revenue: 8006000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

15.3% 2023

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20142014-12-31	Year over year	97.2%	Revenue: 15217000 Open source Revenue: 7718000 Open source
20152015-12-31	Year over year	37.7%	Revenue: 20950000 Open source Revenue: 15217000 Open source
20162016-12-31	Year over year	-30.6%	Revenue: 14531000 Open source Revenue: 20950000 Open source
20172017-12-31	Year over year	-4.9%	Revenue: 13819000 Open source Revenue: 14531000 Open source
20182018-12-31	Year over year	-21.2%	Revenue: 10888000 Open source Revenue: 13819000 Open source
20192019-12-31	Year over year	-27.3%	Revenue: 7917000 Open source Revenue: 10888000 Open source
20202020-12-31	Year over year	-77%	Revenue: 1822000 Open source Revenue: 7917000 Open source
20212021-12-31	Year over year	-77.8%	Revenue: 404000 Open source Revenue: 1822000 Open source
20222022-12-31	Year over year	1,618.6%	Revenue: 6943000 Open source Revenue: 404000 Open source
20232023-12-31	Year over year	15.3%	Revenue: 8006000 Open source Revenue: 6943000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -79.4% 2023

Net margin -71.2% 2023

Free cash flow margin 36.1% 2018

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20142014-12-31	Operating margin	-109.3%	Operating Income: -16626000 Open source Revenue: 15217000 Open source
20152015-12-31	Operating margin	-44.9%	Operating Income: -9404000 Open source Revenue: 20950000 Open source
20162016-12-31	Operating margin	-63.2%	Operating Income: -9177000 Open source Revenue: 14531000 Open source
20172017-12-31	Operating margin	-96.9%	Operating Income: -13386000 Open source Revenue: 13819000 Open source
20182018-12-31	Operating margin	-77.6%	Operating Income: -8451000 Open source Revenue: 10888000 Open source
20192019-12-31	Operating margin	-309.1%	Operating Income: -24468000 Open source Revenue: 7917000 Open source
20202020-12-31	Operating margin	-1,151.3%	Operating Income: -20976000 Open source Revenue: 1822000 Open source
20212021-12-31	Operating margin	-9,961.4%	Operating Income: -40244000 Open source Revenue: 404000 Open source
20222022-12-31	Operating margin	-310.2%	Operating Income: -21534000 Open source Revenue: 6943000 Open source
20232023-12-31	Operating margin	-79.4%	Operating Income: -6360000 Open source Revenue: 8006000 Open source
20142014-12-31	Net margin	-108.4%	Net Income: -16492000 Open source Revenue: 15217000 Open source
20152015-12-31	Net margin	-44.1%	Net Income: -9238000 Open source Revenue: 20950000 Open source
20162016-12-31	Net margin	-61.8%	Net Income: -8973000 Open source Revenue: 14531000 Open source
20172017-12-31	Net margin	-93.8%	Net Income: -12960000 Open source Revenue: 13819000 Open source
20182018-12-31	Net margin	-84.8%	Net Income: -9236000 Open source Revenue: 10888000 Open source
20192019-12-31	Net margin	-301.6%	Net Income: -23877000 Open source Revenue: 7917000 Open source
20202020-12-31	Net margin	-1,147.8%	Net Income: -20913000 Open source Revenue: 1822000 Open source
20212021-12-31	Net margin	-9,770.8%	Net Income: -39474000 Open source Revenue: 404000 Open source
20222022-12-31	Net margin	-303.9%	Net Income: -21102000 Open source Revenue: 6943000 Open source
20232023-12-31	Net margin	-71.2%	Net Income: -5700000 Open source Revenue: 8006000 Open source
20142014-12-31	Free cash flow margin	-65%	Revenue: 15217000 Open source Operating Cash Flow: -9806000 Open source Capital Expenditure: 85000 Open source
20152015-12-31	Free cash flow margin	-33.5%	Revenue: 20950000 Open source Operating Cash Flow: -6948000 Open source Capital Expenditure: 72000 Open source
20162016-12-31	Free cash flow margin	-59.5%	Revenue: 14531000 Open source Operating Cash Flow: -8388000 Open source Capital Expenditure: 255000 Open source
20172017-12-31	Free cash flow margin	-62.8%	Revenue: 13819000 Open source Operating Cash Flow: -8601000 Open source Capital Expenditure: 80000 Open source
20182018-12-31	Free cash flow margin	36.1%	Revenue: 10888000 Open source Operating Cash Flow: 3967000 Open source Capital Expenditure: 36000 Open source
20192019-12-31	Free cash flow margin	Not reported	Revenue: 7917000 Open source Operating Cash Flow: -35981000 Open source
20202020-12-31	Free cash flow margin	Not reported	Revenue: 1822000 Open source Operating Cash Flow: -20034000 Open source
20212021-12-31	Free cash flow margin	Not reported	Revenue: 404000 Open source Operating Cash Flow: -36148000 Open source
20222022-12-31	Free cash flow margin	Not reported	Revenue: 6943000 Open source Operating Cash Flow: -19335000 Open source
20232023-12-31	Free cash flow margin	Not reported	Revenue: 8006000 Open source Operating Cash Flow: -4300000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -4.3M 2023

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20142014-12-31	Operating cash flow	-9806000	Operating Cash Flow: -9806000 Open source
20152015-12-31	Operating cash flow	-6948000	Operating Cash Flow: -6948000 Open source
20162016-12-31	Operating cash flow	-8388000	Operating Cash Flow: -8388000 Open source
20172017-12-31	Operating cash flow	-8601000	Operating Cash Flow: -8601000 Open source
20182018-12-31	Operating cash flow	3967000	Operating Cash Flow: 3967000 Open source
20192019-12-31	Operating cash flow	-35981000	Operating Cash Flow: -35981000 Open source
20202020-12-31	Operating cash flow	-20034000	Operating Cash Flow: -20034000 Open source
20212021-12-31	Operating cash flow	-36148000	Operating Cash Flow: -36148000 Open source
20222022-12-31	Operating cash flow	-19335000	Operating Cash Flow: -19335000 Open source
20232023-12-31	Operating cash flow	-4300000	Operating Cash Flow: -4300000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 3.9M 2018

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20142014-12-31	Free cash flow	-9891000	Operating Cash Flow: -9806000 Open source Capital Expenditure: 85000 Open source
20152015-12-31	Free cash flow	-7020000	Operating Cash Flow: -6948000 Open source Capital Expenditure: 72000 Open source
20162016-12-31	Free cash flow	-8643000	Operating Cash Flow: -8388000 Open source Capital Expenditure: 255000 Open source
20172017-12-31	Free cash flow	-8681000	Operating Cash Flow: -8601000 Open source Capital Expenditure: 80000 Open source
20182018-12-31	Free cash flow	3931000	Operating Cash Flow: 3967000 Open source Capital Expenditure: 36000 Open source
20192019-12-31	Free cash flow	Unavailable	Operating Cash Flow: -35981000 Open source
20202020-12-31	Free cash flow	Unavailable	Operating Cash Flow: -20034000 Open source
20212021-12-31	Free cash flow	Unavailable	Operating Cash Flow: -36148000 Open source
20222022-12-31	Free cash flow	Unavailable	Operating Cash Flow: -19335000 Open source
20232023-12-31	Free cash flow	Unavailable	Operating Cash Flow: -4300000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

16.2% 2021

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2014-12-31	Liabilities / assets	Not reported	Total Assets: 57979000 Open source
2015-12-31	Liabilities / assets	Not reported	Total Assets: 49914000 Open source
2016-12-31	Liabilities / assets	Not reported	Total Assets: 52284000 Open source
2017-12-31	Liabilities / assets	Not reported	Total Assets: 80494000 Open source
20182018-12-31	Liabilities / assets	252.3%	Total Liabilities: 22077000 Open source Total Assets: 8749000 Open source
20192019-12-31	Liabilities / assets	58.3%	Total Liabilities: 10570000 Open source Total Assets: 18144000 Open source
20202020-12-31	Liabilities / assets	19.3%	Total Liabilities: 6499000 Open source Total Assets: 33634000 Open source
20212021-12-31	Liabilities / assets	16.2%	Total Liabilities: 4810000 Open source Total Assets: 29717000 Open source
2022-12-31	Liabilities / assets	Not reported	Total Assets: 10271000 Open source
2023-12-31	Liabilities / assets	Not reported	Total Assets: 11586000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

6.98× 2023

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20142014-12-31	Current assets / current liabilities	9.87×	Current Assets: 51330000 Open source Current Liabilities: 5201000 Open source
20152015-12-31	Current assets / current liabilities	10.69×	Current Assets: 44498000 Open source Current Liabilities: 4162000 Open source
20162016-12-31	Current assets / current liabilities	6.7×	Current Assets: 47867000 Open source Current Liabilities: 7145000 Open source
20172017-12-31	Current assets / current liabilities	4.51×	Current Assets: 76317000 Open source Current Liabilities: 16917000 Open source
20182018-12-31	Current assets / current liabilities	0.41×	Current Assets: 8271000 Open source Current Liabilities: 20095000 Open source
20192019-12-31	Current assets / current liabilities	1.71×	Current Assets: 17969000 Open source Current Liabilities: 10497000 Open source
20202020-12-31	Current assets / current liabilities	5.28×	Current Assets: 33530000 Open source Current Liabilities: 6353000 Open source
20212021-12-31	Current assets / current liabilities	6.15×	Current Assets: 29600000 Open source Current Liabilities: 4810000 Open source
20222022-12-31	Current assets / current liabilities	3.28×	Current Assets: 10083000 Open source Current Liabilities: 3077000 Open source
20232023-12-31	Current assets / current liabilities	6.98×	Current Assets: 11552000 Open source Current Liabilities: 1656000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2014 2014-01-01 – 2014-12-31	−USD 16.49 million Exact value Exact value: -16492000 USD 2014-01-01 – 2014-12-31: -16492000 USD Inspect Net Income Open source Share or cite Citation for Net Income · FRESH TRACKS THERAPEUTICS, INC. · 2014-12-31 FRESH TRACKS THERAPEUTICS, INC. (edgar:819050) Net Income: -16492000 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T23:21:12Z Snapshot: d7dec2b3313a76aff5bd50f95287bb05718949d9458a3dea1eeaf4e9f897a57d Dimensions: Consolidated View: https://fundies.io/companies/edgar/819050/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: -16492000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/819050/000156459017003970/vicl-20161231.xml#93301 Filing: 000156459017003970 The citation records this snapshot. The page link may show a newer release later.	−USD 9.81 million Exact value Exact value: -9806000 USD 2014-01-01 – 2014-12-31: -9806000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · FRESH TRACKS THERAPEUTICS, INC. · 2014-12-31 FRESH TRACKS THERAPEUTICS, INC. (edgar:819050) Operating Cash Flow: -9806000 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T23:21:12Z Snapshot: d7dec2b3313a76aff5bd50f95287bb05718949d9458a3dea1eeaf4e9f897a57d Dimensions: Consolidated View: https://fundies.io/companies/edgar/819050/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -9806000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/819050/000156459017003970/vicl-20161231.xml#118168 Filing: 000156459017003970 The citation records this snapshot. The page link may show a newer release later.	USD 85,000 Exact value Exact value: 85000 USD 2014-01-01 – 2014-12-31: 85000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · FRESH TRACKS THERAPEUTICS, INC. · 2014-12-31 FRESH TRACKS THERAPEUTICS, INC. (edgar:819050) Capital Expenditure: 85000 USD Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T23:21:12Z Snapshot: d7dec2b3313a76aff5bd50f95287bb05718949d9458a3dea1eeaf4e9f897a57d Dimensions: Consolidated View: https://fundies.io/companies/edgar/819050/explain?concept=fundies%3ACapitalExpenditure&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 85000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/819050/000156459017003970/vicl-20161231.xml#120270 Filing: 000156459017003970 The citation records this snapshot. The page link may show a newer release later.	−USD 9.89 million Calculation and evidence -9806000 − 85000 USD Exact free cash flow: -9891000 USD 2014-01-01 – 2014-12-31: -9806000 USD · Inspect Operating Cash Flow · Source 2014-01-01 – 2014-12-31: 85000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · FRESH TRACKS THERAPEUTICS, INC. · 2014-12-31 FRESH TRACKS THERAPEUTICS, INC. (edgar:819050) Free cash flow: -9891000 USD Concept: free-cash-flow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T23:21:12Z Snapshot: d7dec2b3313a76aff5bd50f95287bb05718949d9458a3dea1eeaf4e9f897a57d Dimensions: Consolidated View: https://fundies.io/companies/edgar/819050?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -9806000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/819050/000156459017003970/vicl-20161231.xml#118168 Filing: 000156459017003970 Input fundies:CapitalExpenditure: 85000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/819050/000156459017003970/vicl-20161231.xml#120270 Filing: 000156459017003970 The citation records this snapshot. The page link may show a newer release later.
2015 2015-01-01 – 2015-12-31	−USD 9.24 million Exact value Exact value: -9238000 USD 2015-01-01 – 2015-12-31: -9238000 USD Inspect Net Income Open source Share or cite Citation for Net Income · FRESH TRACKS THERAPEUTICS, INC. · 2015-12-31 FRESH TRACKS THERAPEUTICS, INC. (edgar:819050) Net Income: -9238000 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T23:21:12Z Snapshot: d7dec2b3313a76aff5bd50f95287bb05718949d9458a3dea1eeaf4e9f897a57d Dimensions: Consolidated View: https://fundies.io/companies/edgar/819050/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -9238000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/819050/000156459018005853/vicl-20171231.xml#101232 Filing: 000156459018005853 The citation records this snapshot. The page link may show a newer release later.	−USD 6.95 million Exact value Exact value: -6948000 USD 2015-01-01 – 2015-12-31: -6948000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · FRESH TRACKS THERAPEUTICS, INC. · 2015-12-31 FRESH TRACKS THERAPEUTICS, INC. (edgar:819050) Operating Cash Flow: -6948000 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T23:21:12Z Snapshot: d7dec2b3313a76aff5bd50f95287bb05718949d9458a3dea1eeaf4e9f897a57d Dimensions: Consolidated View: https://fundies.io/companies/edgar/819050/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6948000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/819050/000156459018005853/vicl-20171231.xml#127458 Filing: 000156459018005853 The citation records this snapshot. The page link may show a newer release later.	USD 72,000 Exact value Exact value: 72000 USD 2015-01-01 – 2015-12-31: 72000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · FRESH TRACKS THERAPEUTICS, INC. · 2015-12-31 FRESH TRACKS THERAPEUTICS, INC. (edgar:819050) Capital Expenditure: 72000 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T23:21:12Z Snapshot: d7dec2b3313a76aff5bd50f95287bb05718949d9458a3dea1eeaf4e9f897a57d Dimensions: Consolidated View: https://fundies.io/companies/edgar/819050/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 72000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/819050/000156459018005853/vicl-20171231.xml#129560 Filing: 000156459018005853 The citation records this snapshot. The page link may show a newer release later.	−USD 7.02 million Calculation and evidence -6948000 − 72000 USD Exact free cash flow: -7020000 USD 2015-01-01 – 2015-12-31: -6948000 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 72000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · FRESH TRACKS THERAPEUTICS, INC. · 2015-12-31 FRESH TRACKS THERAPEUTICS, INC. (edgar:819050) Free cash flow: -7020000 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T23:21:12Z Snapshot: d7dec2b3313a76aff5bd50f95287bb05718949d9458a3dea1eeaf4e9f897a57d Dimensions: Consolidated View: https://fundies.io/companies/edgar/819050?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -6948000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/819050/000156459018005853/vicl-20171231.xml#127458 Filing: 000156459018005853 Input fundies:CapitalExpenditure: 72000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/819050/000156459018005853/vicl-20171231.xml#129560 Filing: 000156459018005853 The citation records this snapshot. The page link may show a newer release later.
2016 2016-01-01 – 2016-12-31	−USD 8.97 million Exact value Exact value: -8973000 USD 2016-01-01 – 2016-12-31: -8973000 USD Inspect Net Income Open source Share or cite Citation for Net Income · FRESH TRACKS THERAPEUTICS, INC. · 2016-12-31 FRESH TRACKS THERAPEUTICS, INC. (edgar:819050) Net Income: -8973000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T23:21:12Z Snapshot: d7dec2b3313a76aff5bd50f95287bb05718949d9458a3dea1eeaf4e9f897a57d Dimensions: Consolidated View: https://fundies.io/companies/edgar/819050/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -8973000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/819050/000156459019005633/vicl-20181231.xml#134681 Filing: 000156459019005633 The citation records this snapshot. The page link may show a newer release later.	−USD 8.39 million Exact value Exact value: -8388000 USD 2016-01-01 – 2016-12-31: -8388000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · FRESH TRACKS THERAPEUTICS, INC. · 2016-12-31 FRESH TRACKS THERAPEUTICS, INC. (edgar:819050) Operating Cash Flow: -8388000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T23:21:12Z Snapshot: d7dec2b3313a76aff5bd50f95287bb05718949d9458a3dea1eeaf4e9f897a57d Dimensions: Consolidated View: https://fundies.io/companies/edgar/819050/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -8388000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/819050/000156459019005633/vicl-20181231.xml#160813 Filing: 000156459019005633 The citation records this snapshot. The page link may show a newer release later.	USD 255,000 Exact value Exact value: 255000 USD 2016-01-01 – 2016-12-31: 255000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · FRESH TRACKS THERAPEUTICS, INC. · 2016-12-31 FRESH TRACKS THERAPEUTICS, INC. (edgar:819050) Capital Expenditure: 255000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T23:21:12Z Snapshot: d7dec2b3313a76aff5bd50f95287bb05718949d9458a3dea1eeaf4e9f897a57d Dimensions: Consolidated View: https://fundies.io/companies/edgar/819050/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 255000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/819050/000156459019005633/vicl-20181231.xml#162898 Filing: 000156459019005633 The citation records this snapshot. The page link may show a newer release later.	−USD 8.64 million Calculation and evidence -8388000 − 255000 USD Exact free cash flow: -8643000 USD 2016-01-01 – 2016-12-31: -8388000 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 255000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · FRESH TRACKS THERAPEUTICS, INC. · 2016-12-31 FRESH TRACKS THERAPEUTICS, INC. (edgar:819050) Free cash flow: -8643000 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T23:21:12Z Snapshot: d7dec2b3313a76aff5bd50f95287bb05718949d9458a3dea1eeaf4e9f897a57d Dimensions: Consolidated View: https://fundies.io/companies/edgar/819050?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -8388000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/819050/000156459019005633/vicl-20181231.xml#160813 Filing: 000156459019005633 Input fundies:CapitalExpenditure: 255000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/819050/000156459019005633/vicl-20181231.xml#162898 Filing: 000156459019005633 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 12.96 million Exact value Exact value: -12960000 USD 2017-01-01 – 2017-12-31: -12960000 USD Inspect Net Income Open source Share or cite Citation for Net Income · FRESH TRACKS THERAPEUTICS, INC. · 2017-12-31 FRESH TRACKS THERAPEUTICS, INC. (edgar:819050) Net Income: -12960000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T23:21:12Z Snapshot: d7dec2b3313a76aff5bd50f95287bb05718949d9458a3dea1eeaf4e9f897a57d Dimensions: Consolidated View: https://fundies.io/companies/edgar/819050/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -12960000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/819050/000156459019005633/vicl-20181231.xml#134527 Filing: 000156459019005633 The citation records this snapshot. The page link may show a newer release later.	−USD 8.6 million Exact value Exact value: -8601000 USD 2017-01-01 – 2017-12-31: -8601000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · FRESH TRACKS THERAPEUTICS, INC. · 2017-12-31 FRESH TRACKS THERAPEUTICS, INC. (edgar:819050) Operating Cash Flow: -8601000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T23:21:12Z Snapshot: d7dec2b3313a76aff5bd50f95287bb05718949d9458a3dea1eeaf4e9f897a57d Dimensions: Consolidated View: https://fundies.io/companies/edgar/819050/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -8601000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/819050/000156459019005633/vicl-20181231.xml#160602 Filing: 000156459019005633 The citation records this snapshot. The page link may show a newer release later.	USD 80,000 Exact value Exact value: 80000 USD 2017-01-01 – 2017-12-31: 80000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · FRESH TRACKS THERAPEUTICS, INC. · 2017-12-31 FRESH TRACKS THERAPEUTICS, INC. (edgar:819050) Capital Expenditure: 80000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T23:21:12Z Snapshot: d7dec2b3313a76aff5bd50f95287bb05718949d9458a3dea1eeaf4e9f897a57d Dimensions: Consolidated View: https://fundies.io/companies/edgar/819050/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 80000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/819050/000156459019005633/vicl-20181231.xml#162690 Filing: 000156459019005633 The citation records this snapshot. The page link may show a newer release later.	−USD 8.68 million Calculation and evidence -8601000 − 80000 USD Exact free cash flow: -8681000 USD 2017-01-01 – 2017-12-31: -8601000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 80000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · FRESH TRACKS THERAPEUTICS, INC. · 2017-12-31 FRESH TRACKS THERAPEUTICS, INC. (edgar:819050) Free cash flow: -8681000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T23:21:12Z Snapshot: d7dec2b3313a76aff5bd50f95287bb05718949d9458a3dea1eeaf4e9f897a57d Dimensions: Consolidated View: https://fundies.io/companies/edgar/819050?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -8601000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/819050/000156459019005633/vicl-20181231.xml#160602 Filing: 000156459019005633 Input fundies:CapitalExpenditure: 80000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/819050/000156459019005633/vicl-20181231.xml#162690 Filing: 000156459019005633 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 9.24 million Exact value Exact value: -9236000 USD 2018-01-01 – 2018-12-31: -9236000 USD Inspect Net Income Open source Share or cite Citation for Net Income · FRESH TRACKS THERAPEUTICS, INC. · 2018-12-31 FRESH TRACKS THERAPEUTICS, INC. (edgar:819050) Net Income: -9236000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T23:21:12Z Snapshot: d7dec2b3313a76aff5bd50f95287bb05718949d9458a3dea1eeaf4e9f897a57d Dimensions: Consolidated View: https://fundies.io/companies/edgar/819050/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -9236000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/819050/000081905020000043/a20191231-10k.htm#916801 Filing: 000081905020000043 The citation records this snapshot. The page link may show a newer release later.	USD 3.97 million Exact value Exact value: 3967000 USD 2018-01-01 – 2018-12-31: 3967000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · FRESH TRACKS THERAPEUTICS, INC. · 2018-12-31 FRESH TRACKS THERAPEUTICS, INC. (edgar:819050) Operating Cash Flow: 3967000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T23:21:12Z Snapshot: d7dec2b3313a76aff5bd50f95287bb05718949d9458a3dea1eeaf4e9f897a57d Dimensions: Consolidated View: https://fundies.io/companies/edgar/819050/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 3967000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/819050/000081905020000043/a20191231-10k.htm#948242 Filing: 000081905020000043 The citation records this snapshot. The page link may show a newer release later.	USD 36,000 Exact value Exact value: 36000 USD 2018-01-01 – 2018-12-31: 36000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · FRESH TRACKS THERAPEUTICS, INC. · 2018-12-31 FRESH TRACKS THERAPEUTICS, INC. (edgar:819050) Capital Expenditure: 36000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T23:21:12Z Snapshot: d7dec2b3313a76aff5bd50f95287bb05718949d9458a3dea1eeaf4e9f897a57d Dimensions: Consolidated View: https://fundies.io/companies/edgar/819050/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 36000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/819050/000156459019005633/vicl-20181231.xml#162482 Filing: 000156459019005633 The citation records this snapshot. The page link may show a newer release later.	USD 3.93 million Calculation and evidence 3967000 − 36000 USD Exact free cash flow: 3931000 USD 2018-01-01 – 2018-12-31: 3967000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 36000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · FRESH TRACKS THERAPEUTICS, INC. · 2018-12-31 FRESH TRACKS THERAPEUTICS, INC. (edgar:819050) Free cash flow: 3931000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T23:21:12Z Snapshot: d7dec2b3313a76aff5bd50f95287bb05718949d9458a3dea1eeaf4e9f897a57d Dimensions: Consolidated View: https://fundies.io/companies/edgar/819050?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 3967000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/819050/000081905020000043/a20191231-10k.htm#948242 Filing: 000081905020000043 Input fundies:CapitalExpenditure: 36000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/819050/000156459019005633/vicl-20181231.xml#162482 Filing: 000156459019005633 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 23.88 million Exact value Exact value: -23877000 USD 2019-01-01 – 2019-12-31: -23877000 USD Inspect Net Income Open source Share or cite Citation for Net Income · FRESH TRACKS THERAPEUTICS, INC. · 2019-12-31 FRESH TRACKS THERAPEUTICS, INC. (edgar:819050) Net Income: -23877000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T23:21:12Z Snapshot: d7dec2b3313a76aff5bd50f95287bb05718949d9458a3dea1eeaf4e9f897a57d Dimensions: Consolidated View: https://fundies.io/companies/edgar/819050/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -23877000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/819050/000081905021000029/bbi-20201231.htm#974746 Filing: 000081905021000029 The citation records this snapshot. The page link may show a newer release later.	−USD 35.98 million Exact value Exact value: -35981000 USD 2019-01-01 – 2019-12-31: -35981000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · FRESH TRACKS THERAPEUTICS, INC. · 2019-12-31 FRESH TRACKS THERAPEUTICS, INC. (edgar:819050) Operating Cash Flow: -35981000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T23:21:12Z Snapshot: d7dec2b3313a76aff5bd50f95287bb05718949d9458a3dea1eeaf4e9f897a57d Dimensions: Consolidated View: https://fundies.io/companies/edgar/819050/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -35981000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/819050/000081905021000029/bbi-20201231.htm#1009814 Filing: 000081905021000029 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2020 2020-01-01 – 2020-12-31	−USD 20.91 million Exact value Exact value: -20913000 USD 2020-01-01 – 2020-12-31: -20913000 USD Inspect Net Income Open source Share or cite Citation for Net Income · FRESH TRACKS THERAPEUTICS, INC. · 2020-12-31 FRESH TRACKS THERAPEUTICS, INC. (edgar:819050) Net Income: -20913000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T23:21:12Z Snapshot: d7dec2b3313a76aff5bd50f95287bb05718949d9458a3dea1eeaf4e9f897a57d Dimensions: Consolidated View: https://fundies.io/companies/edgar/819050/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -20913000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/819050/000081905022000016/bbi-20211231.htm#1015012 Filing: 000081905022000016 The citation records this snapshot. The page link may show a newer release later.	−USD 20.03 million Exact value Exact value: -20034000 USD 2020-01-01 – 2020-12-31: -20034000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · FRESH TRACKS THERAPEUTICS, INC. · 2020-12-31 FRESH TRACKS THERAPEUTICS, INC. (edgar:819050) Operating Cash Flow: -20034000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T23:21:12Z Snapshot: d7dec2b3313a76aff5bd50f95287bb05718949d9458a3dea1eeaf4e9f897a57d Dimensions: Consolidated View: https://fundies.io/companies/edgar/819050/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -20034000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/819050/000081905022000016/bbi-20211231.htm#1042601 Filing: 000081905022000016 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2021 2021-01-01 – 2021-12-31	−USD 39.47 million Exact value Exact value: -39474000 USD 2021-01-01 – 2021-12-31: -39474000 USD Inspect Net Income Open source Share or cite Citation for Net Income · FRESH TRACKS THERAPEUTICS, INC. · 2021-12-31 FRESH TRACKS THERAPEUTICS, INC. (edgar:819050) Net Income: -39474000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T23:21:12Z Snapshot: d7dec2b3313a76aff5bd50f95287bb05718949d9458a3dea1eeaf4e9f897a57d Dimensions: Consolidated View: https://fundies.io/companies/edgar/819050/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -39474000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/819050/000081905023000037/frtx-20221231.htm#841265 Filing: 000081905023000037 The citation records this snapshot. The page link may show a newer release later.	−USD 36.15 million Exact value Exact value: -36148000 USD 2021-01-01 – 2021-12-31: -36148000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · FRESH TRACKS THERAPEUTICS, INC. · 2021-12-31 FRESH TRACKS THERAPEUTICS, INC. (edgar:819050) Operating Cash Flow: -36148000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T23:21:12Z Snapshot: d7dec2b3313a76aff5bd50f95287bb05718949d9458a3dea1eeaf4e9f897a57d Dimensions: Consolidated View: https://fundies.io/companies/edgar/819050/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -36148000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/819050/000081905023000037/frtx-20221231.htm#861570 Filing: 000081905023000037 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2022 2022-01-01 – 2022-12-31	−USD 21.1 million Exact value Exact value: -21102000 USD 2022-01-01 – 2022-12-31: -21102000 USD Inspect Net Income Open source Share or cite Citation for Net Income · FRESH TRACKS THERAPEUTICS, INC. · 2022-12-31 FRESH TRACKS THERAPEUTICS, INC. (edgar:819050) Net Income: -21102000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T23:21:12Z Snapshot: d7dec2b3313a76aff5bd50f95287bb05718949d9458a3dea1eeaf4e9f897a57d Dimensions: Consolidated View: https://fundies.io/companies/edgar/819050/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -21102000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/819050/000162828024011460/frtx-20231231.htm#572835 Filing: 000162828024011460 The citation records this snapshot. The page link may show a newer release later.	−USD 19.34 million Exact value Exact value: -19335000 USD 2022-01-01 – 2022-12-31: -19335000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · FRESH TRACKS THERAPEUTICS, INC. · 2022-12-31 FRESH TRACKS THERAPEUTICS, INC. (edgar:819050) Operating Cash Flow: -19335000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T23:21:12Z Snapshot: d7dec2b3313a76aff5bd50f95287bb05718949d9458a3dea1eeaf4e9f897a57d Dimensions: Consolidated View: https://fundies.io/companies/edgar/819050/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -19335000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/819050/000162828024011460/frtx-20231231.htm#587942 Filing: 000162828024011460 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2023 2023-01-01 – 2023-12-31	−USD 5.7 million Exact value Exact value: -5700000 USD 2023-01-01 – 2023-12-31: -5700000 USD Inspect Net Income Open source Share or cite Citation for Net Income · FRESH TRACKS THERAPEUTICS, INC. · 2023-12-31 FRESH TRACKS THERAPEUTICS, INC. (edgar:819050) Net Income: -5700000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T23:21:12Z Snapshot: d7dec2b3313a76aff5bd50f95287bb05718949d9458a3dea1eeaf4e9f897a57d Dimensions: Consolidated View: https://fundies.io/companies/edgar/819050/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -5700000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/819050/000162828024011460/frtx-20231231.htm#614789 Filing: 000162828024011460 The citation records this snapshot. The page link may show a newer release later.	−USD 4.3 million Exact value Exact value: -4300000 USD 2023-01-01 – 2023-12-31: -4300000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · FRESH TRACKS THERAPEUTICS, INC. · 2023-12-31 FRESH TRACKS THERAPEUTICS, INC. (edgar:819050) Operating Cash Flow: -4300000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T23:21:12Z Snapshot: d7dec2b3313a76aff5bd50f95287bb05718949d9458a3dea1eeaf4e9f897a57d Dimensions: Consolidated View: https://fundies.io/companies/edgar/819050/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4300000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/819050/000162828024011460/frtx-20231231.htm#615018 Filing: 000162828024011460 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

131 filings · 3,220 latest values · 3,207 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000819050, 819050, BBI, FRTX, VICL, edgar:819050

Also known as BRICKELL BIOTECH, INC., Brickell Biotech, Inc., FRESH TRACKS THERAPEUTICS, INC., Fresh Tracks Therapeutics, Inc., VICAL INC, VICAL, INC.

FRESH TRACKS THERAPEUTICS, INC.

Latest quarter

Revenue

Operating cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

2023 2023-01-01 – 2023-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation